ESMO gave me a chance to help make a difference: a personal reflection on the occasion of receiving the 2015 ESMO Award

por Cherny, Nathan I
Publicado 2016

Palliative care: needs of advanced breast cancer patients

por Cherny, Nathan I, Paluch-Shimon, Shani, Berner-Wygoda, Yael
Publicado 2018

ESMO and WHO: 14 years of working in partnership on cancer control

por Ullrich, Andreas, Ciardiello, Fortunato, Bricalli, Gracemarie, Cherny, Nathan I, Eniu, Alexandru
Publicado 2016

Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?

por Gribben, John G., de Vries, Elisabeth, Cherny, Nathan I., Sonneveld, Pieter
Publicado 2020

Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care

por Hui, David, Cherny, Nathan I, Wu, Jimin, Liu, Diane, Latino, Nicola Jane, Strasser, Florian
Publicado 2018

Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?

por Eniu, Alexandru, Cherny, Nathan I, Bertram, Melanie, Thongprasert, Sumitra, Douillard, Jean-Yves, Bricalli, Gracemarie, Vyas, Malvika, Trapani, Dario
Publicado 2019

Feasibility of Large-Scale Implementation of an Electronic Patient-Reported Outcome Remote Monitoring System for Patients on Active Treatment at a Community Cancer Center

por Cherny, Nathan I., Parrinello, Christina M., Kwiatkowsky, Lavi, Hunnicutt, Jeff, Beck, Thaddeus, Schaefer, Eric, Thurow, Tracy, Kolodziej, Michael
Publicado 2022

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

por Paluch-Shimon, Shani, Cherny, Nathan I, de Vries, Elisabeth G E, Dafni, Urania, Piccart, Martine J, Latino, Nicola Jane, Cardoso, Fatima
Publicado 2020

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

por Knapen, Daan Geert, Cherny, Nathan I, Zygoura, Panagiota, Latino, Nicola Jane, Douillard, Jean-Yves, Dafni, Urania, de Vries, Elisabeth G E, de Groot, Derk Jan
Publicado 2020

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules

por Dafni, Urania, Karlis, Dimitris, Pedeli, Xanthi, Bogaerts, Jan, Pentheroudakis, George, Tabernero, Josep, Zielinski, Christoph C, Piccart, Martine J, de Vries, Elisabeth G E, Latino, Nicola Jane, Douillard, Jean-Yves, Cherny, Nathan I
Publicado 2017

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0

por Kiesewetter, Barbara, Dafni, Urania, de Vries, Elisabeth G E, Barriuso, Jorge, Curigliano, Giuseppe, González-Calle, Veronica, Galotti, Martina, Gyawali, Bishal, Huntly, Brian, Jaeger, Ulrich, Latino, Nicola Jane, Malcovati, Luca, Oosting, Sjoukje, Ossenkoppele, Gert, Piccart, Martine, Raderer, Markus, Scarfò, Lydia, Trapani, Dario, Zielinski, Christoph C, Wester, Ruth, Zygoura, Panagiota, Macintyre, Elizabeth, Cherny, Nathan I
Publicado 2023

EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies

por Kiesewetter, Barbara, Cherny, Nathan I, Boissel, Nicolas, Cerisoli, Francesco, Dafni, Urania, de Vries, Elisabeth G E, Ghia, Paolo, Gökbuget, Nicola, González-Calle, Verónica, Huntly, Brian, Jäger, Ulrich, Latino, Nicola Jane, Douillard, Jean-Yves, Malcovati, Luca, Mateos, María-Victoria, Ossenkoppele, Gert J, Porkka, Kimmo, Raderer, Markus, Ribera, Josep-Maria, Scarfò, Lydia, Wester, Ruth, Zygoura, Panagiota, Sonneveld, Pieter
Publicado 2020